Alan Whitmore BMBCh, BSc, PhD

Alan Whitmore is a clinician scientist trained at the Universities of London and Oxford. He has over 20 years experience in biomedical research and clinical practice (ophthalmology and general medicine) obtained in Cambridge, Oxford, London, Newcastle and the USA. He was previously a Lecturer in Ophthalmology and Ophthalmic Pathology at the UCL Institute of Ophthalmology, additionally holding the post of Institute Medical Advisor; and prior to that an MRC Research Fellow at the UCL LMCB.

His work is known internationally and includes peer-reviewed publications in Science, JCB and other high impact journals. It has encompassed electrophysiology, biochemistry, neural development, cell biology, neurodegenerative processes, ocular drug delivery and the application of computational approaches to biomedical research. Dr Whitmore is CEO of Lumemed Ltd, an honorary senior lecturer at the UCL School of Pharmacy, Director of Research at e-Therapeutics PLC and remains a practising physician.